Arunjyoti Bio Q1 Results FY27: PAT at Rs 1 Crore, Down 50% as Revenue Slips 11%

Arunjyoti Bio Q1 results FY27 were announced on Thursday, 9 July 2026, with the Hyderabad based co-packing company reporting a standalone net profit (PAT) of around Rs 1 crore, down 50% from about Rs 2 crore in Q1 FY26. Revenue in the Arunjyoti Bio Q1 results FY27 slipped 11% year on year to roughly Rs 8 crore, while gross profit fell a much steeper 66% to about Rs 1 crore.

Shares of Arunjyoti Bio Ventures closed almost unchanged at Rs 5.73 on the BSE, down 0.17% on results day. The muted reaction to the Arunjyoti Bio Q1 results FY27 suggests the market had already priced in a soft quarter, with the stock trading near the bottom of its 52 week range for weeks before the announcement.

Click Here – Get Free Investment Predictions

Arunjyoti Bio Q1 Results FY27 Financial Highlights

The June quarter showed profit falling far faster than revenue, and that margin squeeze defines the Arunjyoti Bio Q1 results FY27. The table below summarises the standalone numbers against the year ago quarter, as reported in rounded crore terms.

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 8 Cr	Rs 9 Cr	-11%
Gross Profit	Rs 1 Cr	Rs 3 Cr	-66%
Net Profit (PAT)	Rs 1 Cr	Rs 2 Cr	-50%

Figures in the Arunjyoti Bio Q1 results FY27 are standalone for the quarter ended 30 June 2026 and rounded to the nearest crore by exchange data providers, so the percentage changes are a better guide to the trend than the absolute numbers.

Arunjyoti Bio Q1 Results FY27 Performance Analysis

Get Personalised Guidance from a SEBI-Registered Investment Advisor

The margin story matters more than the revenue story here. An 11% revenue decline produced a 66% fall in gross profit in the Arunjyoti Bio Q1 results FY27, which points to higher input, conversion or fixed costs eating into the co-packing spread earned per unit during the quarter.

Co-packing is a volume business with thin margins, where capacity utilisation decides profitability. The weakness in the Arunjyoti Bio Q1 results FY27 likely reflects underutilised lines and the ramp up costs of new capacity, including the jelly pouch line at Jangaon commissioned for Tata Consumer Products in March 2026.

The silver lining in the Arunjyoti Bio Q1 results FY27 is that the company stayed profitable. After a full year loss of about Rs 4.54 crore in FY26, which included write-offs of around Rs 2.74 crore, a roughly Rs 1 crore quarterly PAT at least marks a return to positive territory.

Arunjyoti Bio Q1 Results FY27: Key Business Factors

1. Co-Packing for Multinational Clients

Arunjyoti Bio Ventures, formerly Century 21st Portfolio and incorporated in 1986, provides co-packing services for beverages and non carbonated water for MNC clients. Client concentration cuts both ways, bringing steady volumes but limited pricing power.

2. New Tata Consumer Products Line

Commercial production of five pack jelly pouches for Tata Consumer Products began at the Jangaon facility on 10 March 2026. Scaling this line is the clearest growth lever visible after the Arunjyoti Bio Q1 results FY27, since marquee client volumes can lift utilisation across the plant.

3. Small Balance Sheet with Thin Coverage

The company carries a low interest coverage ratio and reported negative return on equity over the last three years. Every quarter of positive earnings, including the Arunjyoti Bio Q1 results FY27, strengthens a balance sheet that has little room for error.

Dividend Details

No dividend, buyback or bonus issue was announced along with the Arunjyoti Bio Q1 results FY27. Given the FY26 loss and the ongoing investment in new co-packing lines, cash conservation is the sensible path, and shareholders should not expect payouts in the near term.

Arunjyoti Bio Q1 Results FY27 Outlook for the Full Year

The year hinges on utilisation. If the Tata Consumer Products jelly pouch line scales through the summer beverage season, revenue and margins can both recover from the levels seen in the June quarter. Investors reading the Arunjyoti Bio Q1 results FY27 should track quarterly gross margins, disclosures on new client additions and any update on capacity expansion at Jangaon. A second consecutive profitable quarter would meaningfully improve the picture after the FY26 loss.

Arunjyoti Bio Stock Performance After the Q1 Results

Download the Univest iOS App or Univest Android App to track Arunjyoti Bio live share price and upcoming quarterly results.

Arunjyoti Bio share price ended at Rs 5.73 on the BSE on 9 July 2026, down 0.17%, an essentially flat close that shows the Arunjyoti Bio Q1 results FY27 held no surprise for the market. The stock trades under BSE scrip code 530881.

The counter has ranged between a 52 week low of Rs 5.02 and a 52 week high of Rs 12.71, and is down around 33% over six months, with a market capitalisation near Rs 107 crore. The Arunjyoti Bio Q1 results FY27 do little to justify the valuation of about 3.75 times book value, which still builds in a recovery the numbers have yet to confirm.

Key Risks

Investors going through the fine print of the Arunjyoti Bio Q1 results FY27 should weigh the following risks.

1. Client Concentration

Dependence on a small number of multinational clients means the loss or scale down of one contract could remove a large share of revenue overnight.

2. Thin Margins and Cost Pressure

The 66% gross profit fall this quarter shows how quickly co-packing economics deteriorate when utilisation dips or input costs rise, leaving little cushion for the bottom line, as the Arunjyoti Bio Q1 results FY27 demonstrate.

3. Micro Cap Volatility

A Rs 107 crore market cap stock trading near its 52 week low can swing sharply on small volumes, and the counter has already lost a third of its value in six months.

Conclusion

Arunjyoti Bio Q1 results FY27 show revenue down 11% to about Rs 8 crore and PAT halving to roughly Rs 1 crore, with a 66% gross profit fall exposing the cost pressure in its co-packing business. A return to quarterly profit after the FY26 loss and the scaling Tata Consumer Products line are the positives in the Arunjyoti Bio Q1 results FY27, against client concentration and thin margins. Investors should treat this as a high risk micro cap and consult a SEBI-registered advisor before acting on the numbers.

Frequently Asked Questions on Arunjyoti Bio Q1 Results FY27

When were the Arunjyoti Bio Q1 results FY27 announced?

Ans. The Arunjyoti Bio Q1 results FY27 were announced on Thursday, 9 July 2026, when the board approved the standalone unaudited financial results for the quarter ended 30 June 2026.

What is the PAT in Arunjyoti Bio Q1 results FY27?

Ans. The PAT in Arunjyoti Bio Q1 results FY27 stood at around Rs 1 crore, down 50% from about Rs 2 crore in Q1 FY26, as weaker margins in the co-packing business pulled profitability lower despite only a modest revenue decline.

What was the revenue in Arunjyoti Bio Q1 results FY27?

Ans. Revenue in the Arunjyoti Bio Q1 results FY27 fell 11% year on year to around Rs 8 crore from Rs 9 crore, while gross profit dropped a sharper 66%, indicating cost pressure in the company’s co-packing operations.

What does Arunjyoti Bio Ventures do as a company?

Ans. Arunjyoti Bio Ventures is a Hyderabad based co-packer incorporated in 1986, formerly known as Century 21st Portfolio. It provides co-packing services for beverages and non carbonated water for multinational clients, and recently commissioned a jelly pouch line at Jangaon for Tata Consumer Products in March 2026.

How did Arunjyoti Bio share price react to the Q1 results FY27?

Ans. Arunjyoti Bio share price closed largely flat, down 0.17% at Rs 5.73 on the BSE on 9 July 2026, the day the Arunjyoti Bio Q1 results FY27 were announced, with the stock trading near the lower end of its 52 week range of Rs 5.02 to Rs 12.71.

Did Arunjyoti Bio declare a dividend with the Q1 results FY27?

Ans. No dividend, buyback or bonus issue was announced along with the Arunjyoti Bio Q1 results FY27. The company reported a loss of about Rs 4.54 crore in FY26, which makes payouts unlikely in the near term.

Is Arunjyoti Bio a good buy after the Q1 results FY27?

Ans. The Arunjyoti Bio Q1 results FY27 show falling profits in a small cap co-packing business that reported a full year loss in FY26, though the new Tata Consumer Products line offers a growth avenue. This is a high risk micro cap. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.